期刊文献+

伴有FGFR1重排的白血病/淋巴瘤一例报告附文献复习 被引量:2

原文传递
导出
摘要 伴有FGFRl重排的白血病/淋巴瘤,即8p11骨髓增殖综合征(EMS),是一种较罕见的血液系统恶性肿瘤,以髓系增生异常、嗜酸粒细胞增多、常伴发淋巴母细胞淋巴瘤(lymphoblast lymphoma,LBL)为其主要特征。
出处 《中华血液学杂志》 CAS CSCD 北大核心 2010年第1期52-54,共3页 Chinese Journal of Hematology
  • 相关文献

参考文献24

  • 1肖志坚,郝玉书,卞寿庚,秘营昌,李建波,陈辉树,钱林生,丁现超,王岩,薛艳萍,赵耀中.8p11骨髓增殖综合征——一例报告及文献复习[J].中华血液学杂志,1996,17(11):566-568. 被引量:10
  • 2赵喜晨,王建祥.8p11骨髓增殖综合征的研究进展[J].国外医学(输血及血液学分册),2005,28(3):212-215. 被引量:5
  • 3Swerdlow SH, Campo E, Hanis NL, et al. WHO classification of tumors of haematopoietic and lymphoid tissues. 4th ed. Lyon : International Agency for Research Cancer Press,2008: 74-75.
  • 4Macdonald D, Aguiar RC, Mason PJ, et al. A new myeloproliferatire disorder associated with chromosomal translocations involving 8p11 : a review. Leukemia, 1995, 9 : 1628-1630.
  • 5Friedhoff F, Rajendra B, Moody R,et al. Novel reciprocal translocation between chromosomes 8 and 9 found in a patient with myeloproliferative disorder. Cancer Genct Cytogenet, 1983, 9:391-394.
  • 6Lewis JP, Jenks H, Lazerson J. Philadelphia chromosome-negative chronic myelogenous leukemia in a chiht with t(8 ;9 ) ( p11 or 12; q34). Am J Pediatr Hematol Oncol, 1983, 5:265-269.
  • 7Abruzzo LV, Jaffe ES, Cotelingam JD,et al. T-cell lymphoblastic lymphoma with eosinophilia associated with subsequent myeloid malignancy. Am J Surg Pathol, 1992, 16:236-245.
  • 8Yamamoto K, Kawano H, Nishikawa S, et al. A biphenotypic transformation of 8p11 myeloproliferafive syndrome with CEP1/ FGFRI fusion gene. Eur J Haematol, 2006, 77:349-354.
  • 9Xiao S, Nalabolu SR, Aster JC, et al. FGFR1 is fused with a novel zinc-finger gene, ZNF198, in the t (8; 13 ) leukaemia/lymphoma syndrome. Nat Genet, 1998, 18:84-87.
  • 10Guasch G, Mack GJ, Popovici C, et al. FGFRt is fused to the centrosome-associated protein CEP110 in the 8p12 stem cell myeloproliferative disorder with t ( 8 ; 9 ) ( p12 ; q33 ). Blood, 2000, 95 : 1788-1796.

二级参考文献22

  • 1Macdonald D, Reiter A, Cross NC. The 8p11 myeloproliferative syndrome: a distinct clinical entity caused by constitutive activation of FGFR1. Acta Haematol,2002,107(2):101-107.
  • 2Chaffanet M, Popovici C, Leroux D, et al. t(6;8), t(8;9) and t(8;13) translocations associated with stem cell myeloproliferative disorders have close or identical breakpoints in chromosome region 8p11-12. Oncogene,1998, 16(7):945-949.
  • 3Sohal J, Chase A, Mould S, et al. Identification of four new translocations involving FGFR1 in myeloid disorders. Genes Chromosomes Cancer, 2001, 32(2):155-163.
  • 4Xiao S, Nalabolu SR, Aster JC, et al. FGFR1 is fused with a novel zinc-finger gene, ZNF198, in the t(8;13) leukaemia/lymphoma syndrome. Nat Genet, 1998, 18(1):84-87.
  • 5Kulkarni S, Reiter A, Smedley D, et al. The genomic structure of ZNF198 and location of breakpoints in the t(8;13) myeloproliferative syndrome. Genomics, 1999, 55(1):118-121.
  • 6Ollendorff V, Guasch G, Isnardon D, et al. Characterization of FIM-FGFR1, the fusion product of the myeloproliferative disorder-associated t(8;13) translocation. J Biol Chem, 1999, 274(38):26922-26930.
  • 7Xiao S, McCarthy JG, Aster JC, et al. ZNF198-FGFR1 transforming activity depends on a novel proline-rich ZNF198 oligomerization domain. Blood, 2000, 96(2):699-704.
  • 8Guasch G, Mack GJ, Popovici C,et al. FGFR1 is fused to the centrosome-associated protein CEP110 in the 8p12 stem cell myeloproliferative disorder with t(8;9)(p12;q33). Blood, 2000, 95(5):1788-1796.
  • 9Popovici C, Zhang B, Gregoire MJ, et al. The t(6;8)(q27;p11) translocation in a stem cell myeloproliferative disorder fuses a novel gene, FOP, to fibroblast growth factor receptor 1. Blood, 1999, 93(4):1381-1389.
  • 10Guasch G, Ollendorff V, Borg JP, et al. 8p12 stem cell myeloproliferative disorder: the FOP-fibroblast growth factor receptor 1 fusion protein of the t(6;8) translocation induces cell survival mediated by mitogen-activated protein kinase and phosphatidylinositol 3-kinase/Akt/mTOR pathways. Mol Cell Biol, 2001, 21(23):8129-8142.

共引文献11

同被引文献34

  • 1赵喜晨,王建祥.8p11骨髓增殖综合征的研究进展[J].国外医学(输血及血液学分册),2005,28(3):212-215. 被引量:5
  • 2肖志坚,郝玉书,卞寿庚,秘营昌,李建波,陈辉树,钱林生,丁现超,王岩,薛艳萍,赵耀中.8p11骨髓增殖综合征——一例报告及文献复习[J].中华血液学杂志,1996,17(11):566-568. 被引量:10
  • 3Bain BJ, Gilliland DG, Horny HP, et al. Myeloid and lymphoid neoplasms with eosinophilia and abnormalities of PDGFRA, PDGFRB or FGFRI. In: Swerdlow SH, Harris NL, Jaffe ES, et al. WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon: IARC; 2008:68 -73.
  • 4Jackson CC, Medeiros LJ, Miranda RN. 8p11 myeloproliferative syndrome: a review. Hum Pathol, 2010; 41 (4) :461 -476.
  • 5Shaffer LG, Tommerup N. ISCN ( 2005 ) : An international system for human cytogenetic nomenclature. Switzerland Karger: Basel, publication. 2005:55 -58.
  • 6Abruzzo LV, Jaffe ES, Cotelingam JD, et al. T-cell lymphoblastic lymphoma with eosinophilia associated with subsequent myeloid malignancy. Am J Surg Pathol, 1992; 16(3) :236 -245.
  • 7Macdonald D, Aguiar RC, Mason PJ, et al. A new myeloproliferative disorder associated with chromosomal translocations involving 8p11 : a review. Leukemia, 1995; 9(10) :1628 - 1630.
  • 8Kuskonmaz B, Kafali C, Akcoren Z, et al. The 8p11 myeloproliferafive syndrome in a 3-year-old child. Leuk Res, 2008 ; 32 ( 1 ) : 198 - 199.
  • 9Friedhoff F, Rajendra B, Moody R, et al. Novel reciprocal translocation between chromosomes 8 and 9 found in a patient with myeloproliferative disorder. Cancer Genet Cytogenet, 1983 ; 9 (4) : 391 - 394.
  • 10Macdonald D, Reiter A, Cross NC. The 8p11 myeloproliferative syndrome: a distinct clinical entity caused by constitutive activation of FGFR1. Acta Haematol, 2002; 107(2) :101 - 107.

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部